Auriant Mining AB
Auriant Mining AB (publ.) applies for delisting from Nasdaq First North Growth Market
Auriant Mining AB (publ.) applies for delisting from Nasdaq First North Growth Market
Auriant Mining AB (the “Company”) announced on 14 October 2024 its plan to apply for delisting of the Company’s shares upon expiration of three months from the date of the abovementioned announcement. In accordance with the plan, the Company has today applied for delisting from Nasdaq First North Growth Market. The last day of trading in the Company’s shares on Nasdaq First North Growth Market will be announced as soon as the Company has received this information from Nasdaq.
For more information, please contact:
Danilo Lange, CEO
tel: +7 495 109 02 82
e-mail: d.lange@auriant.com
Company name: Auriant Mining AB
Short name: AUR
ISIN-code: SE0001337213
Website: www.auriant.com
Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in the Republic of Tyva, Zabaikalye and the Republic of Khakassia. The company has currently four assets, including two operating mines (Tardan and Alluvial at Staroverinskaya), one early stage exploration asset and one development asset.
Since July 19, 2010, Auriant Mining´s shares are traded on Nasdaq First North Growth Market under the short name AUR. For more information, please visit www.auriant.com. G&W Fondkommission is Certified Adviser to Auriant, for more information please visit www.gwkapital.se.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Investeringsforeningen Jyske Invest18.12.2025 08:03:55 CET | Pressemeddelelse
Investeringsforeningen Jyske Invest har ajourført prospekt
GEVORKYAN, a.s.18.12.2025 08:00:00 CET | Press release
Dr. Kalliwoda: Convincing Q3 2025 Results with a Bright Outlook
EXEL INDUSTRIES18.12.2025 07:58:00 CET | Press release
EXEL Industries: Full-year 2024–2025 results
Sampo plc18.12.2025 07:30:00 CET | Press release
Sampo plc’s share buybacks 17 December 2025
Sequana Medical NV18.12.2025 07:00:00 CET | Press release
Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom